Vasoactive intestinal peptidetest results The measurement of serum vasoactive intestinal peptide, often abbreviated as VIP, is a critical diagnostic tool in modern medicine. Vasoactive intestinal peptide is a fascinating molecule, a 28-amino-acid multifunctional peptide that plays a significant role in numerous physiological processesEndocrine cells derived chemokine vasoactive intestinal polypeptide .... Initially identified for its potent vasodilator activity, its influence extends far beyond the intestine, impacting gastrointestinal functions, immune responses, and even neuroendocrine regulationVasoactive intestinal polypeptide (VIP) is a neurohormone produced in the central nervous system as well as in the neurons of the gastrointestinal (GI), .... This article delves into the significance of serum vasoactive intestinal peptide, its role in various conditions, and what elevated or decreased levels might indicate.
Vasoactive intestinal peptide, also known as vasoactive intestinal polypeptide or simply VIP, is a neuropeptide. It is synthesized and released by various cells, including neurons in the central and peripheral nervous systems, as well as endocrine cells. Its presence is not confined to the gastrointestinal tissues; it is also found in other organs and can be detected in serum and plasma samples. The VIP axis is a complex system, and its proper functioning is crucial for maintaining homeostasis. Research has indicated that a dysfunctional vasoactive intestinal peptide axis can be linked to various pathological conditions.
The primary application of measuring serum vasoactive intestinal peptide levels is in the diagnosis and management of specific medical conditions, most notably vasoactive intestinal polypeptide-producing tumors, also known as VIPomas. These very rare pancreatic neuroendocrine tumors (PNETs) are characterized by excessive production and secretion of VIP.
When a VIPoma is suspected, particularly in patients presenting with chronic diarrheal diseases, a Vasoactive Intestinal Polypeptide; Vip Test is often ordered.作者:K Nishino·2025—Serum VIP levels are higher in patients with atrial fibrillation with LVAs, suggesting its potential as a noninvasive biomarker for detecting these areas. The serum vasoactive intestinal peptide level is used to measure the VIP level in the bloodSerum Vasoactive Intestinal Peptide as a Novel Biomarker .... A significantly elevated level, often described as serum VIP levels greater than 200 pg/mL, is highly suggestive of a VIPoma. For instance, patients with VIPoma generally have elevated serum VIP levels ranging from 60 to as high as 2100 pg/mL. It is often recommended that serum vasoactive intestinal peptide levels be measured ideally during a bout of diarrhea, as this can further aid in diagnosis.
Beyond VIPomas, research suggests that serum VIP levels may serve as a novel biomarker in other conditions.Vasoactive intestinal peptide (VIP) is a 28-amino-acid peptide known for its potent vasodilator activity and role in various biological functions across ... Studies have indicated that Serum VIP levels are higher in patients with atrial fibrillation with LVAs (Left Ventricular Abnormalities), suggesting its potential as a noninvasive biomarker for detecting these areas.Vasoactive Intestinal Polypeptide (VIP), Plasma - ARUP Lab Furthermore, research has explored the association between serum vasoactive intestinal peptide and conditions like Alzheimer's disease, with some studies observing that serum VIP levels were elevated in AD patients when compared with those in normal controls.Serum levels of vasoactive intestinal peptide (VIP) in ...
Understanding the normal range of serum vasoactive intestinal peptide is crucial for accurate interpretation. In healthy controls, a median VIP-serum level of 42.44 +/- 2.540 pg/ml (range, 12.9-98.5 pg/ml) has been reported. However, these levels can vary.Vipoma - Endocrine and Metabolic Disorders
Research has investigated serum levels of vasoactive intestinal peptide (VIP) in specific patient groups. For example, studies have examined serum levels of vasoactive intestinal peptide (VIP) in patients with pancreatic cancer and colonic adenocarcinoma compared to healthy individuals. Some findings suggest that Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis, highlighting a potential link between genetic factors and VIP levels in certain inflammatory conditions.
Conversely, other studies have pointed towards lower VIP levels in specific contexts.Endocrine cells derived chemokine vasoactive intestinal polypeptide ... For instance, one study concluded that EA patients with low baseline VIP levels have worse disease outcome, underscoring the prognostic significance of VIP levels in certain patient cohorts.
The multifaceted nature of Vasoactive Intestinal Peptide means it is involved in a wide array of biological functions. VIP plays a key role in regulating smooth muscle relaxation, secretion of water and electrolytes in the intestines, and modulation of immune responses. Its potent vasodilator activity contributes to blood flow regulation. Additionally, VIP acts as a mitogenic factor for embryonic neurons in the sympathetic nervous system, underscoring its importance in neural development.2025年8月10日—In healthy controls, amedian VIP-serum level of 42.44 +/- 2.540 pg/ml(range, 12.9-98.5 pg/ml) was found, while patients with pancreatic cancer ... The neuropeptide vasoactive intestinal peptide (VIP) has been identified as inhibiting osteoclastogenesis and suppressing inflammation, pointing to its anti-inflammatory properties.
The Vasoactive intestinal peptide test is a straightforward blood test designed to quantify the amount of VIP in the bloodstream. To ensure accurate results, specific patient preparation is usually required. Generally, a patient should be fasting for 10-12 hours prior to the collection of the specimen.Plasma Vasoactive Intestinal Polypeptide Concentration ... The blood sample is typically collected in a pre-chilled tube, especially when testing for vasoactive intestinal polypeptide-producing tumors. The Vasoactive Intestinal Polypeptide; Vip Test is readily available through various laboratory services, offering a fast and accurate diagnosis for timely treatment.
While VIPomas are a primary focus, other conditions can influence serum VIP levels. For example, increased serum vasoactive intestinal peptide levels have been associated with acute exacerbation of chronic obstructive pulmonary disease (COPD)作者:W Wang·2019·被引用次数:12—Background: The neuropeptidevasoactive intestinal peptide(VIP) has been identified as inhibiting osteoclastogenesis and suppressing inflammation.. Furthermore, research continues to explore the role of VIP in conditions such as atrial fibrillation with LVAs, and its potential correlation with substance P and vasoactive intestinal peptide in dermatological conditions like bullous diseases, where serum concentrations of SP-IR and VIP-IR were mostly low or non-detectable in some casesSerum Vasoactive Intestinal Peptide as a Novel Biomarker ....
In conclusion, the measurement of serum vasoactive intestinal peptide is a valuable diagnostic and prognostic toolVasoactive intestinal peptidealso known as the vasoactive intestinal polypeptide or VIP is a peptide ... Vasoactive intestinal peptide [Presence] in Serum or .... From aiding in the detection of rare tumors to offering insights into inflammatory and cardiovascular conditions, VIP's significance in human health is undeniable2015年11月4日—Increasedserum vasoactive intestinal peptidelevels appeared associated with acute exacerbation of chronic obstructive pulmonary disease, .... Continued research into the complex roles of this peptide and its gene polymorphisms promises to further illuminate its impact on well-being and disease.Substance P and vasoactive intestinal peptide in bullous ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.